Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Which Altcoins Have Strong Tech And Low Market Cap combines advanced tech with room to grow. This intro guides evaluation of core tech, roadmap, and market activity.
28,655 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
New findings from the 2025 tiaa-gflec study confirms that very low financial literacy triples the odds of being finan...
When a top executive sells a large block of stock, investors often wonder about the meaning behind the move. This gui...
The Las Vegas Strip bid farewell to a family-driven dining concept after almost four years. This article breaks down ...
When a senior leader at Black Stone Minerals sells a sizeable block of units, it can ripple through the stock. This a...
When a Fed chair speaks about prices being too high, markets hear implications for rates. This article unpacks what t...
The Solana Institute leads a bipartisan push to protect open-source developers as the CLARITY Act advances in the Sen...
A coalition of silicon valley insiders warns that the United States is underprepared for modern warfare, with wide-re...
A failing satellite firm pivoted by selling spectrum to SpaceX, triggering a sharp stock surge and turning investor b...
Stocks edge higher pre-market as oil nears $100 a barrel, lifting energy names while weighing inflation and growth pr...
Optimum (OPTU) is reshaping its strategy in 2026. This original analysis dives into the Q1 results, margins, and capi...
The AI rally cooled, but the opportunity remains. This guide shares three AI stocks investors should load up on and a...